Form 4: Madrigal Pharmaceuticals Executive Waltermire Sells Shares
SEC Form 4 Filing
Robert E. Waltermire, Senior VP, Chief Pharma Dev. at Madrigal Pharmaceuticals, sold 1,036 shares of common stock at a price of $231.34 on May 21, 2024.
Summary
- On May 21, 2024, Robert E. Waltermire, Senior VP, Chief Pharma Dev. at Madrigal Pharmaceuticals, sold 1,036 shares of common stock.
- The sale price was $231.34 per share.
- Following the transaction, Waltermire directly owns 5,500 shares of Madrigal Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sentiment is neutral as it simply reports a stock sale.
Industry Context
Executive stock sales are a common occurrence and are often scrutinized by investors for insights into a company's prospects, although they don't always indicate a negative outlook.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of stock sale transaction |
| 05/22/2024 | Date of Power of Attorney execution |
| 05/23/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.